ImmuneSpec
Latest round
- Seed
Last raised
- Mar 2023
Total raised
- $1.3M
Investors
- 1
About ImmuneSpec
Based in Antwerp, Belgium, and founded in 2023 by CEO Elise Pepermans and CSO Geert Baggerman, ImmuneSpec BV operates as a biotechnology research company that provides an advanced immune peptidomics platform for the identification of immunogenic peptides. ImmuneSpec BV provides a drug development process including purification methods for generating several immunopeptides, spectrometry analysis to capture immunogenic regions, and data-analysis methodology for coverage of immunogenic regions. The company offers life science companies, biotech companies, and CROs in the development of broad-spectrum vaccines, personalized medicine, and immunotherapeutics. In addition, the firm provides an immune peptidomics platform for the identification of immunogenic peptides.
Who invested in ImmuneSpec
1 investor across 1 round
See all investors in ImmuneSpec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 23, 2023
Amount
$1.3M
Investors
Questions about ImmuneSpec
Who invested in ImmuneSpec?
ImmuneSpec has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmuneSpec raised?
ImmuneSpec has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImmuneSpec last raise money?
ImmuneSpec's most recent round on record is a Seed, in Mar 2023.
What does ImmuneSpec do?
Based in Antwerp, Belgium, and founded in 2023 by CEO Elise Pepermans and CSO Geert Baggerman, ImmuneSpec BV operates as a biotechnology research company that provides an advanced immune peptidomics platform for the identification of immunogenic peptides.
Where is ImmuneSpec headquartered?
ImmuneSpec is headquartered in Antwerp, Belgium.
Which VCs invest in companies like ImmuneSpec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at ImmuneSpec's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ImmuneSpec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.